Open Nav

Nigel Mouncey


Joint Genome Institute (JGI)

Dr. Nigel Mouncey joined the DOE Joint Genome Institute in 2017 as the fourth Director in its 20-year history. After stints as a senior research scientist in molecular biology at Roche Vitamins, Inc. in New Jersey and DSM Nutritional Products in Switzerland, he joined Dow AgroSciences in Indianapolis in 2008 and served as Bioengineering and Bioprocessing R&D Director and Leader from 2011 onward. There, Mouncey directed a 70-member R&D team that supported the growth of a highly successful natural product insecticide that has since generated hundreds of millions of dollars of revenue and significant societal benefit, through isolating, optimizing, and scaling-up of new production strains for commercial manufacturing by fermentation. He also built an integrated and highly effective bioprocessing team comprising high-throughput screening, metabolic engineering, engineering biology, systems biology, enzymology, protein expression, fermentation and analytical capabilities. His team also developed production strains and fermentation processes for other molecules such as a new fungicide, propionic acid and long-chain alcohols, as well as supporting the discovery of new crop traits.

Nigel has his Ph.D. in Biochemistry, University of Sussex and won the 2016 World Bio Markets Bio-based Business Person of the Year award. He is serving on numerous committees including the Publications Committee (which is chairs since 2016) and the Diversity Committee (2015-2016) of the Society for Industrial Microbiology and Biotechnology (SIMB). Nigel has 13 granted and 33 pending patents and numerous publications.

This speaker's sessions: